CD36 and breast carcinoma: Furthermore, CD36 expression promotes radio and chemoresistance in breast cancer (Feng et al., 2020), AML (Woolthuis et al., 2016; Zhang et al., 2020), MCL (Zaja et al., 2014), and CRC (Park et al., 2019), which are known to be (at least partially) mediated by CSCs.